Evidence map›Paper›PMID 34889712›Full record

ArticleBioengineered2021

Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression.

Yuqing Zhang, Yuping Hu, Aihong Pan, Lei He, Jin Wang, Fangfang Zhou, Yongbo Lei, Yuanyuan Wang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. MicroRNAs and Gene Regulatory Networks Related to Cleft Lip and Palate.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yuqing ZhangDepartment of Pediatrics,The first people's Hospital of Hefei, South District Binhu Hospital of Hefei First People's Hospital, Neonates Department, Hefei, China.
Yuping HuDepartment of Pediatrics,The first people's Hospital of Hefei, South District Binhu Hospital of Hefei First People's Hospital, Neonates Department, Hefei, China.
Aihong PanNursing Department,The first people's Hospital of Hefei, South District Binhu Hospital of Hefei First People's Hospital, Nursing Department, Hefei, China.
Lei HeNursing Department,The first people's Hospital of Hefei, South District Binhu Hospital of Hefei First People's Hospital, Nursing Department, Hefei, China.
Jin WangNursing Department,The first people's Hospital of Hefei, South District Binhu Hospital of Hefei First People's Hospital, Nursing Department, Hefei, China.
Fangfang ZhouDepartment of Pediatrics,The first people's Hospital of Hefei, South District Binhu Hospital of Hefei First People's Hospital, Neonates Department, Hefei, China.
Yongbo LeiGraduate school,Institute of Nursing, Far Eastern University, Master in Art of Nursing, Far Eastern University, Sampaloc, Manila, Philippines.
Yuanyuan WangDepartment of Pediatrics, Maternal and Child Health Hospital of Weifang City, Maternal and Child Health Hospital of Weifang City, Weifang, China.
Hefei First People's Hospital · CNFar Eastern University · PHWeifang Maternity and Child Care Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding (lncRNA) neuroblastoma highly expressed 1 (NHEG1) has been reorganized as a prognostic factor in neuroblastoma (NB), but the molecular mechanisms in the suppression of neuroblastoma remain to be elucidated. In our study, we explored the functional roles of lncRNA NHEG1 in neuroblastoma and the underlying molecular mechanism. We collected NB tumor samples and adjacent normal tissues to compare lncRNA NHEG1 expression. Through bioinformatic target prediction, we selected potential downstream effectors of lncRNA NHEG1 for functional validation in NB cell lines. We observed that lncRNA NHEG1 was significantly upregulated in NB tissues as compared to the normal tissues. In NB tissues, lncRNA NHEG1 expression showed an inverse correlation with hsa-miR-665 (miR-655), but a positive correlation with high mobility group box 1 (HMGB1). In NB cell lines, lncRNA NHEG1 knockdown caused the upregulation of miR-665 and the downregulation of HMGB1. Through a series of functional assays, we further demonstrated that lncRNA Nheg1 knockdown suppressed cell proliferation, migration and invasion of NB cells, which could be rescued by miR-665 inhibitor and HMGB1 overexpression. Together, our data demonstrated that lncRNA NHEG1 serves as a competitive partner to negatively regulate the activity of miR-665, which relieves the inhibition on HMGB1 expression and promotes the aggressive phenotype of neuroblastoma cells. Our study indicates that lncRNA NHEG1/miR-665/HMGB1 axis may play an important role in regulating the aggressiveness and the progression of neuroblastoma.

Indexed as

Disease ProgressionGene Expression Regulation, NeoplasticBase SequenceCell Line, TumorCell MovementCell ProliferationChild, PreschoolFemaleGene SilencingHMGB1 ProteinHumansInfantMaleMicroRNAsNeoplasm InvasivenessNeuroblastomaHMGB1 ProteinHMGB1 protein, humanMicroRNAsMIRN665 microRNA, humanRNA, Long NoncodingHMGB1Lncrna NHEG1miR-665neuroblastoma

Identifiers

PMID34889712
PMCPMC8810076
OpenAlexW4200186599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.